Clinical trial

Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients

NCT00461617

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-08-01

PhasePHASE3

Study timeline

Study start (unknown)2006-08-01Date precision: month

Registry last updated2008-10-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Interventions

MitiglinideDRUG

Sponsors & collaborators

Kissei Pharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00461617 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.